AMB Labs Microbubbles

About Advanced Microbubbles

Advanced Microbubbles is addressing the critical challenge of inefficient drug delivery in oncology, where less than 1% of injected drugs typically reach their target. Their core innovation is the creation of stable, large, monodisperse microbubbles that, when combined with ultrasound, can non-invasively open biological barriers to enable precise delivery of various therapeutic agents. The platform has shown promising preclinical results in models of pancreatic cancer, neuroblastoma, and for blood-brain barrier opening, positioning the company to advance a versatile, drug-agnostic delivery technology.

Therapeutic Areas